Law Offices of Thomas J. Lamb

  • Free Case Evaluation
  • Mesothelioma & Asbestos Diseases
  • Legal Compensation
  • Asbestos Overview
  • Common Questions
  • About Our Firm

Clinical Practice Guidelines for the Management of Malignant Pleural Mesothelioma

August 19, 2020 By Thomas Lamb

Clinical practice guidelines for the management of malignant pleural mesothelioma were released in May 2020 by the European
Respiratory Society, European Society of Thoracic Surgeons, European Association for Cardio-Thoracic Surgery, and European Society for Radiotherapy and Oncology.

Epidemiology Research Priorities

The task force recommends large international epidemiological studies to determine the relationship between pleural plaques and malignant pleural mesothelioma.

Additionally, well-designed clinical trials are needed to determine the effectiveness of CT screening in populations exposed to asbestos.

Further research is needed, and highly encouraged, on biomarkers for malignant pleural mesothelioma, as the ones proposed previously have not proven useful for diagnosis, prognosis, or clinical follow-up for disease monitoring.

Staging Research Priorities

The task force encourages increased prospective data collection regarding tumor thickness and volume measurements.

Additionally, it encourages the prospective use of volumetric assessment software for pretreatment staging investigations.

Other prognostic factors that are important are routine use of the Brims score, in combination with other scores, as part of clinical trials for prospective validation.

Surgery Recommendations & Research Priorities

The task force recommends thorascopic talc poudrage to control recurrent malignant pleural mesothelioma effusions as their first choice to achieve pleurodesis in patients with expanded lungs.

In symptomatic patients who are stable enough to undergo surgery but who will not benefit from chemical pleurodesis or an indwelling catheter, or in whom these have failed, the task force suggests palliative video-assisted thoracic surgery/partial pleurectomy to obtain pleural effusion control.

Malignant pleural mesothelioma patients who are being considered for radical surgery (eg, extrapleural pneumonectomy or pneumonectomy/decortication) should be included in national/international surgical registries or prospective randomized controlled clinical trials.

[Article continues at original source]


 Asbestos & Mesothelioma Information

  Asbestos-Mesothelioma Case Evaluation
Free.  Confidential.  No Obligation.

Filed Under: Medicine, Mesothelioma Tagged With: malignant pleural mesothelioma (MPM), mesothelioma, mesothelioma treatments

Do I Have A Possible Case?

If you have a possible asbestos disease or mesothelioma lawsuit, you can get a free, confidential, and no obligation case review from asbestos lawyer Tom Lamb.

Main Navigation Menu

  • Who Was Exposed to Asbestos
  • NC Asbestos Exposure Sites
  • Asbestos-Contaminated Talc
  • Asbestos Diseases
  • Legal Compensation
  • Free Case Evaluation
  • Frequently Asked Questions
  • About Our Law Firm
  • Attorney Tom Lamb
  • Collection of Articles
  • Sitemap

Attorney Tom Lamb

TJL@LambLawOffice.com

Phone: 800-426-9535

Lumina Station, Suite 225
1908 Eastwood Road
Wilmington, North Carolina

Please know that you can use our Quick Contact Form to tell us about your case.

Lamb Law Office Newsletter

Lamb Law Office Newsletter provides periodic updates about some of the cases that we are working on for clients, as well as an information resource you might find helpful.

Subscribe using Form below.

Subscription Form

* indicates required

Our Other Website

Lamb Law Office

Contact Information

Law Offices of Thomas J. Lamb, P.A.
1908 Eastwood Road, Suite 225
Wilmington, North Carolina 28403
910-256-2971 | 800-426-9535
TJL@LambLawOffice.com

  • Home
  • Disclaimer and Copyright Notices
  • Sitemap

Copyright © 2023 · Law Offices of Thomas J. Lamb, P.A.